Oxford Biomedica Announces Total Voting Rights Update
Company Announcements

Oxford Biomedica Announces Total Voting Rights Update

Oxford BioMedica (GB:OXB) has released an update.

Oxford Biomedica, a leader in cell and gene therapy, announced a total of 105,923,083 voting rights as of October 31, 2024. This figure is significant for shareholders to assess their stakes in the company. OXB continues to drive innovation in viral vector manufacturing, collaborating with top pharmaceutical firms globally.

For further insights into GB:OXB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskOxford BioMedica Sees Shift in Voting Rights
TheFlyOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorgan
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App